Tesamorelin

FDA approvedPrescriptionChecked 19 Oct 2026

Peptide Chooser editorial team. Every claim links to its source. Prices checked 19 Oct 2026.

FDA approved: an FDA-approved product exists. FDA source, 19 Oct 2026. Our muscle and hormones page lists it.

Evidence by goal

What each goal page that lists it says, word for word, with its sources. The evidence rating comes from a goal page's checked options table; a goal without one shows "Not rated".

Goal	Evidence in people	What the goal page says
Muscle and hormonesTesamorelin (Egrifta)	Not rated	A daily shot approved only to reduce belly fat in people with HIV. Sold off-label by clinics for "growth hormone".

FDA warning letters

Our letters list is by company, not by substance. The letters page lists all 172, each with its subject and a link to fda.gov; filter it by a company name.

FDA warning letters

Sources

FDA, status of Tesamorelin, 19 Oct 2026: https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name%3A%22Tesamorelin%22&limit=100